Sputnik V
Russia to send 30 lakh Sputnik V doses to India by May-end
New Delhi/IBNS/UNI: Russia has sent over 2 lakh doses of Sputnik V vaccine to India, and the number will reach 30 lakh by May-end, said DB Venkatesh Varma, Indian Ambassador to Russia.
India has been using two vaccines-indigenously produced Bharat Biotech's Covaxin and AstraZeneca's vaccine produced by Serum Institute of India as Covishield..
With Sputnik V, developed by the Russian Direct Investment Fund (RDIF), the health authorities in India will have a third vaccine to aid the mega vaccination drive, which has been extended to 18-44 years age group since May 1.
Meanwhile, Dr Reddy’s Laboratories, the partner of Sputnik V Covid vaccine in India, on Saturday stated that efforts were on to produce the vaccine in five Indian sites with collaborative efforts.
The pharma giant representatives Kapil, Mallikarjuna Rao, Vemuri Vishwanath, and Ravi who interacted with the Governor during the review, said that they were confident to make 15 to 20 crore doses of vaccine available during the next six months through imports and manufacturing within the country.
“The equitable allocation of vaccines will be ensured to all the States in our country,” they added.
They informed the Governor that by the end of July, they would get 2 crore doses of vaccine consignments from Russia.
India has already received two consignments of vaccines from Russia. Inoculations with Sputnik V in Hyderabad started on May 14 following the arrival of the first batch of the vaccine on May 1.
Sputnik V was approved for use in India on April 12 and granted emergency use authorisation. India is the leading production hub for Sputnik V.
The pricing of the Sputnik V COVID-19 vaccine, currently capped at Rs 995 per dose (including GST), is expected to come down once local manufacturing of the vaccine begins, according to a company spokesperson from Dr Reddy's Laboratories earlier.
The company was currently engaged in discussions to bring the single-dose vaccine Sputnik Light to India, the spokesperson added.
Dr Reddy's Laboratories had earlier a contract of 250 million vaccine units with the Russian Direct Investment Fund (RDIF).
Sputnik V has already been soft-launched in India on May 14 as part of the pilot rollout.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
